Press Release
Morgan Advanced Materials plc
24 April 2024
Capital Markets Update
"Accelerating growth"
Morgan Advanced Materials plc will hold a Capital Markets Update this afternoon in London for institutional investors and analysts.
The update will include presentations by our senior leadership team, focussing on the acceleration of our growth as a global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications.
The presentation will include a detailed explanation of our recently announced increase in investment into capacity for the Semiconductor market, as well as on the growth opportunities in our Core markets.
We will also set out our enhanced financial framework and re-iterate our capital allocation policy:
| - | Accelerating Organic Revenue Growth. We expect to be towards the top of our 4% - 7% p.a. guidance range over the next four years with the investments we are making |
| - | Attractive Margins. 12.5% - 15% adjusted operating profit margin, with a clear path towards the top end of the range, underpinned by organic growth and business simplification |
| - | Delivering EPS Growth. Achieving enhanced growth in adjusted Earnings per Share, ahead of organic revenue growth, driven by a combination of organic growth, M&A and shareholder returns |
| - | Sustaining ROIC. 17% - 20% ROIC |
| - | Leverage Range. 1.0x to 1.5x, or up to 2.0x adjusted EBITDA post acquisition, utilising our strong balance sheet to fund our organic growth and incremental M&A |
The presentation will be made available at www.morganadvancedmaterials.com at 14:00 today, along with a recording of the presentation that will be made available following the event.
No new information on current year trading will be shared at the event.
For further enquiries:
| Pete Raby, CEO Richard Armitage, CFO | Morgan Advanced Materials plc | 01753 837000 |
| Nina Coad | Brunswick | 0207 404 5959 |
Cautionary Statement
For the purposes of the following disclaimers, references to this 'presentation' shall be deemed to include references to the presenters speeches, the question and answer session and any other related verbal or written communications.
This presentation contains forward-looking statements. These have been made by the Directors in good faith based on the information available to them up to the time of their approval of this report. The Directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements.
The Directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.